Member Info for mulledwine

Margins Overall the group margin was down 0.3% (excluding the London 2012 contract) on a constant currency basis, due to contract phasing in the UK government businesses and US government budgetary cuts. Cash solutions margins were broadly in line with the same period as last year, with a stronger performance in the cash solutions businesses in most developing markets. Acquisitions & Divestments During the first nine months of the year, we invested £8m in deferred consideration in respect of prior year acquisitions and £95m in capability-building acquisitions such as a leading security provider in Brazil, and fire and safety consulting businesses in Ireland, Netherlands and Belgium. Olympics contract loss provision As stated previously, our current estimate remains that the loss on the London 2012 contract will be in the region of £50m and this amount was provided for at the half year and taken as an exceptional item. This estimate is based on our current expectation of the financial outcome including reasonable estimates of costs where at this date there is still uncertainty. Financial position Our financial position continues to be strong and we remain on track to meet our cash conversion target of 85% of PBITA for the full year.

INTERIM MANAGEMENT STATEMENT G4S, the world's leading international secure outsourcing solutions group, reports today on trading for the year to date, including an overview of financial performance to 30 September 2012. Overview of the financial performance for the nine months to 30 September 2012 In the first nine months of 2012, overall revenues compared to the same period last year, excluding the London 2012 contract, grew by 6.3% at constant exchange rates and by 4.1% at actual exchange rates. Including the London 2012 contract, revenues grew by 9.2% at constant rates and by 6.9% at actual exchange rates. As expected, the group operating margin was lower compared to the same period in 2011. Organic Growth Overall organic growth was good at 5.5% (8% including the London 2012 contract), with 9% in developing markets and 4% (8% including the London 2012 contract) in developed markets. In secure solutions, organic growth was 6% (9% including the London 2012 contract), despite an 11% decline in the US classified government business. Overall, growth was helped by a continued strong performance in developing markets, UK government and North America commercial businesses. In cash solutions, organic growth was 3% overall. Developing markets grew 10% and developed markets were broadly flat. Organic growth in developed markets is expected to improve as new contract wins in the UK come onboard fully.

http://www.investegate.co.uk/g4s-plc-(gfs)/one/g4s-plc-uk--dk--interim-management-statement/20121106070152H5174/

Outlook As stated previously, in the Telecoms division, the Company expects to continue to increase contributions from the OEM agreements signed late last year as well as generate growth in the IP business. In the Medical division, all parts of the business are expected to achieve growth due to: · Expansion of the distribution business in Eastern Europe · Significant growth of the diagnostics business following the receipt of certifications as it expands its production and distribution to meet demand · Increase in demand for the medical waste disposal solutions Looking ahead, despite the weak global trading environment, the Company expects both the Telecoms and Medical divisions to continue to make good progress and grow in 2013.

Financial position The Company's balance sheet remains strong and at 30 September the effective cash balance stood at $41.3 million, very similar to the cash position at 30 June 2012 of $42.3 million

Interim Management Statement Achieved break-even for Q3 2012 as expected BATM Advanced Communications Limited (LSE: BVC; TASE: BATM), a leading provider of real-time technologies for the networked telecoms and medical laboratory equipment markets, announces its interim management statement for the period from 1 July 2012 to 30 September 2012. Trading update Total revenues in the third quarter of 2012 were $24.7 million compared with $26.0 million for the equivalent period in 2011, excluding revenues from the discontinued legacy telecom business. Revenue from the Company's contract with Nokia amounted to only $0.6m in this quarter compared with $2.8m in Q3 2011. As a result, excluding the Nokia contribution, the Company's revenues grew year-on-year by 3.9%. Specifically, the sales mix consisted of 55% from the Telecoms division and 45% from the Medical division compared with 59% and 41% respectively in Q3 2011, highlighting the growing contribution of the Medical business. The blended gross margin for the quarter was 31.7% compared with 35.9% for the same period of 2011, primarily due to sales mix and a lower margin in the Telecoms division, which is expected to slightly improve with the higher revenues anticipated in Q4 2012. The decline in gross profit margin in the quarter was offset by lower operating expenses at both the Medical and Telecoms divisions. As a result, as anticipated in its interim results statement, the Company achieved a cumulative break-even result for the nine months to 30 September 2012 and expects to continue into profitability in the final quarter.

http://www.investegate.co.uk/batm-advanced-comm-(bvc)/rns/interim-management-statement/201211050700052735Q/

A premium valuation is deserved China Healthcare is the largest division. Placing a similar rating to its quoted Chinese peers (19.5x) gives a market cap of £218m, meaning that MediPharma, Consumer Products and the cash pile (over $20m) are essentially in for free. A sum-of-theparts valuation suggests a market cap of £275m is justified, with scope for further upside if elements of the R&D pipeline are partnered

http://www.edisoninvestmentresearch.co.uk/researchreports/HutchisonChinaMediTechQV051112.pdf

Valuation: Tempting FY13 rating We have reduced our FY12 EBITDA and PBT estimates by €3m to fully reflect the recent plant downtime and lost volume described above. There should be no impact on subsequent years’ performance and estimates here are unchanged. Consequently, current year multiples are inflated by somewhat constrained earnings. Looking at the following years reaffirms previous comments on value ratings with an FY13 P/E of 7.9x and a group EV/EBITDA below 3.2x. With the prospect of an interruption-free year in FY13 showcasing plant enhancements, further share buy-backs must be a tempting option.

http://www.edisoninvestmentresearch.co.uk/researchreports/Powerfluteupdate051112.pdf

David Cameron has embarked on a major push to sell as many as 100 British-made fighter jets worth billions to Gulf leaders. On a three-day visit to the Middle East, the Prime Minister will promote the new Eurofighter Typhoons - which are partly made in Britain - to the United Arab Emirates, Saudi Arabia and Oman. Any new contracts would be a significant boost for BAE Systems, the UK’s flagship defence manufacturer, which last month saw merger talks with European EADS collapse after the German Government blocked the tie-up. It is highly unusual for a Prime Minister to be so open about the need to win defence contracts. His intervention suggests BAE and the Government think they have a good chance of persuading the UAE to buy 60 Typhoon fighter jets, even though it has engaged in protracted negotiations to buy Rafale jets from France’s Dassault, The Telegraph says.

Grahame Falconer, Chief Executive of Densitron said: "We are disappointed that the Company will not sustain its recent growth in the current financial year. However, the current strength of our order book along with the development of intellectual property suggests that the outlook for the business is positive and we look forward to the coming year with confidence. "In moving the Newcastle property claim into mediation, we hope to be able to draw a line under this issue and allow management to focus all its energies on developing the core business."

Trading and Legal Proceedings Update Densitron Technologies plc announces that it expects its results for the year to 31 December 2012 to be behind market expectations. It does, however, expect that the operating profit for the year will be ahead of that achieved in 2011. The primary cause of this is certain orders being received later than anticipated as a result of which the Directors now expect the deliveries associated with these orders, and therefore resultant sales, to be delayed into 2013. Orders booked in the first 9 months of the year, however, remain strong and are in excess of 10% higher than those booked in the same period in 2011. This trend is expected to continue for the remainder of the year. In March 2012 the Directors announced that the Company had received notification of legal proceedings against it in respect of a lease of a property located at Wallsend, Tyne and Wear, near Newcastle. Full details of the action are set out in the announcement dated 1 March 2012. The claim is defended but in the interests of progressing the matter in an expedient manner, the directors have resolved to enter into mediation proceedings to seek a negotiated settlement if the other parties to the litigation are prepared to do so.

http://www.investegate.co.uk/densitron-tech-plc-(dsn)/rns/trading-and-legal-proceedings-update/201211050700042505Q/

Indian Subsidiary Financial Results (under Indian GAAP) for the Quarter ended 30 September 2012 KSK Power Ventur plc ("the Company"), the power project company listed on the London Stock Exchange, with interests in multiple power plants and businesses across India, is pleased to announce that its Indian subsidiary, KSK Energy Ventures Limited ("KSKEV"), the equity shares of which are listed and traded on the National Stock Exchange of India Limited ("NSE") and the BSE Limited ("BSE"), has filed with the NSE and BSE on 3 November 2012, its un-audited financial results for the three months ended 30 September 2012. Full details of the KSKEV un-audited results are available on the KSKEV website (www.ksk.co.in) and the NSE website (www.nseindia.com) and the BSE website (www.bseindia.com).

http://www.investegate.co.uk/ksk-power-ventur-plc-(ksk)/rns/indian-subsidiary-financial-results/201211050700062768Q/

Was thinking of an investment here - I think Im glad I held off as this may drop a little - hard to say

Rupert Pearce, Inmarsat's Chief Executive Officer, said, "The third quarter saw continued customer take-up of new services across our business sectors. In maritime, another very positive quarter was driven by the benefit of pricing initiatives earlier in the year and by the continuing strong take-up of FleetBroadband. Despite the headwinds we face from the on-going withdrawal from Afghanistan, results for our land mobile business improved with growth from IsatPhone Pro and positive underlying data growth due mainly to new BGAN subscribers.

Inmarsat plc - Highlights · Total revenue excluding LightSquared $322m up 5% (2011: $308m) · Wholesale maritime revenues up 17% · Over 2,100 FleetBroadband terminals added in Q3 · Over 71,000 IsatPhone Pro subscribers at end of Q3 · XpressLink gaining market share with new orders · Honeywell 5-year capacity commitment for business aviation with Global Xpress Inmarsat Group Limited - Third Quarter Highlights · Inmarsat Global MSS revenue $187m up 3% (2011: $181m) · Inmarsat Solutions revenue $206m up 4% (2011: $197m) · Total EBITDA excluding LightSquared $161m (2011: $172m) · MSS active terminals up 13%